User login
WASHINGTON – Coronary catheterization procedures done via transradial access produce significantly better patient outcomes, compared with transfemoral approaches, but transradial also leads to substantially higher radiation exposure to the operator, according to an analysis of 650 procedures.
When operators performed transradial coronary catheterizations they received on average nearly twice the radiation dose to their chest as they did when they performed transfemoral procedures, in a randomized trial that included 14 interventional cardiologists, Alessandro Sciahbasi, MD, reported at the annual meeting of the American College of Cardiology.
Radiation exposures to the operators’ wrists and eyes showed no significant differences between the two catheterization routes. The difference was limited to thorax exposure.
“These data worry me,” commented Sunil V. Rao, MD, a long-time advocate for increased transradial catheterizations in U.S. practice. “We are pretty obsessive about radiation detection in our catheterization laboratory,” said Dr. Rao, an interventional cardiologist at Duke University in Durham, N.C.
The RAD-MATRIX substudy focused on the radiation exposures received by 14 participating operators who wore radiation dosimeters on their wrist, chest, and near their eyes during each procedure. All operators performed both transradial and transfemoral catheterizations with the choice dictated by the randomization protocol. The transradial procedures underwent further randomization to access through either the patient’s left or right arm. The full analysis included 398 procedures performed by transfemoral access, and 252 with transradial access with 131 via the left forearm and 121 via the right forearm.
The analysis showed that, when the operators performed transradial catheterizations, they received an average, normalized, effective dose to their thorax of 2.3 mcSv per procedure and 1.2 mcSv when performing transfemoral catheterization, a statistically significant difference. The exposures from left and from right transradial access did not differ significantly. Concurrently with Dr. Sciahbasi’s report at the meeting the results also appeared in an online article (J Am Coll Card. 2017 Mar 18. doi: 10.1016/j.jacc.2017.03.018).
The analysis also showed a 10-fold variability in exposure level among the 14 participating operators. Dr. Sciahbasi hypothesized that this reflected substantive differences in the degree of radiation protection used by each operator and suggested this implied that some interventionalists were not protecting themselves from exposure as thoroughly as possible.
RAD-MATRIX received partial funding from The Medicines Company and Terumo. Dr. Sciahbasi had no disclosures. Dr. Rao has been a consultant to Boehringer Ingelheim, Cardinal Health, Corindus, Cardiovascular Systems, and Medtronic.
mzoler@frontlinemedcom.com
On Twitter @mitchelzoler
The findings from RAD-MATRIX are alarming. Although radiation exposure is generally acknowledged as an occupational hazard of interventional cardiology, it is rarely taken seriously. It is common to see individuals performing procedures without wearing leaded eyewear, or casually strolling into catheterization laboratories without wearing appropriate aprons. The topic is often approached jocularly with comments about childbearing with little thought given to cancer risk. However, the radiation-induced health risks to adults are nontrivial and outweigh by an order of magnitude any risk for hereditary disease.
Although the findings of RAD-MATRIX are unlikely to impede the swelling tide of the transradial approach, the implications are very important. They should prompt radial and femoral operators to heed radiation safety principles. In addition, we need rigorously collected registry data concerning the safety of percutaneous coronary interventions for operators and staff.
Neil S. Kleiman, MD , is professor of cardiology at Houston Methodist. Norman J. Kleiman, PhD , is director of the Eye Radiation on Environmental Research Laboratory at Columbia University in New York. They had no disclosures. These comments are from an editorial they wrote to accompany the published RAD-MATRIX results (J Am Coll Card. 2017 Mar 18. doi: 10.1016/j.jacc.2017.03.016 ).
The findings from RAD-MATRIX are alarming. Although radiation exposure is generally acknowledged as an occupational hazard of interventional cardiology, it is rarely taken seriously. It is common to see individuals performing procedures without wearing leaded eyewear, or casually strolling into catheterization laboratories without wearing appropriate aprons. The topic is often approached jocularly with comments about childbearing with little thought given to cancer risk. However, the radiation-induced health risks to adults are nontrivial and outweigh by an order of magnitude any risk for hereditary disease.
Although the findings of RAD-MATRIX are unlikely to impede the swelling tide of the transradial approach, the implications are very important. They should prompt radial and femoral operators to heed radiation safety principles. In addition, we need rigorously collected registry data concerning the safety of percutaneous coronary interventions for operators and staff.
Neil S. Kleiman, MD , is professor of cardiology at Houston Methodist. Norman J. Kleiman, PhD , is director of the Eye Radiation on Environmental Research Laboratory at Columbia University in New York. They had no disclosures. These comments are from an editorial they wrote to accompany the published RAD-MATRIX results (J Am Coll Card. 2017 Mar 18. doi: 10.1016/j.jacc.2017.03.016 ).
The findings from RAD-MATRIX are alarming. Although radiation exposure is generally acknowledged as an occupational hazard of interventional cardiology, it is rarely taken seriously. It is common to see individuals performing procedures without wearing leaded eyewear, or casually strolling into catheterization laboratories without wearing appropriate aprons. The topic is often approached jocularly with comments about childbearing with little thought given to cancer risk. However, the radiation-induced health risks to adults are nontrivial and outweigh by an order of magnitude any risk for hereditary disease.
Although the findings of RAD-MATRIX are unlikely to impede the swelling tide of the transradial approach, the implications are very important. They should prompt radial and femoral operators to heed radiation safety principles. In addition, we need rigorously collected registry data concerning the safety of percutaneous coronary interventions for operators and staff.
Neil S. Kleiman, MD , is professor of cardiology at Houston Methodist. Norman J. Kleiman, PhD , is director of the Eye Radiation on Environmental Research Laboratory at Columbia University in New York. They had no disclosures. These comments are from an editorial they wrote to accompany the published RAD-MATRIX results (J Am Coll Card. 2017 Mar 18. doi: 10.1016/j.jacc.2017.03.016 ).
WASHINGTON – Coronary catheterization procedures done via transradial access produce significantly better patient outcomes, compared with transfemoral approaches, but transradial also leads to substantially higher radiation exposure to the operator, according to an analysis of 650 procedures.
When operators performed transradial coronary catheterizations they received on average nearly twice the radiation dose to their chest as they did when they performed transfemoral procedures, in a randomized trial that included 14 interventional cardiologists, Alessandro Sciahbasi, MD, reported at the annual meeting of the American College of Cardiology.
Radiation exposures to the operators’ wrists and eyes showed no significant differences between the two catheterization routes. The difference was limited to thorax exposure.
“These data worry me,” commented Sunil V. Rao, MD, a long-time advocate for increased transradial catheterizations in U.S. practice. “We are pretty obsessive about radiation detection in our catheterization laboratory,” said Dr. Rao, an interventional cardiologist at Duke University in Durham, N.C.
The RAD-MATRIX substudy focused on the radiation exposures received by 14 participating operators who wore radiation dosimeters on their wrist, chest, and near their eyes during each procedure. All operators performed both transradial and transfemoral catheterizations with the choice dictated by the randomization protocol. The transradial procedures underwent further randomization to access through either the patient’s left or right arm. The full analysis included 398 procedures performed by transfemoral access, and 252 with transradial access with 131 via the left forearm and 121 via the right forearm.
The analysis showed that, when the operators performed transradial catheterizations, they received an average, normalized, effective dose to their thorax of 2.3 mcSv per procedure and 1.2 mcSv when performing transfemoral catheterization, a statistically significant difference. The exposures from left and from right transradial access did not differ significantly. Concurrently with Dr. Sciahbasi’s report at the meeting the results also appeared in an online article (J Am Coll Card. 2017 Mar 18. doi: 10.1016/j.jacc.2017.03.018).
The analysis also showed a 10-fold variability in exposure level among the 14 participating operators. Dr. Sciahbasi hypothesized that this reflected substantive differences in the degree of radiation protection used by each operator and suggested this implied that some interventionalists were not protecting themselves from exposure as thoroughly as possible.
RAD-MATRIX received partial funding from The Medicines Company and Terumo. Dr. Sciahbasi had no disclosures. Dr. Rao has been a consultant to Boehringer Ingelheim, Cardinal Health, Corindus, Cardiovascular Systems, and Medtronic.
mzoler@frontlinemedcom.com
On Twitter @mitchelzoler
WASHINGTON – Coronary catheterization procedures done via transradial access produce significantly better patient outcomes, compared with transfemoral approaches, but transradial also leads to substantially higher radiation exposure to the operator, according to an analysis of 650 procedures.
When operators performed transradial coronary catheterizations they received on average nearly twice the radiation dose to their chest as they did when they performed transfemoral procedures, in a randomized trial that included 14 interventional cardiologists, Alessandro Sciahbasi, MD, reported at the annual meeting of the American College of Cardiology.
Radiation exposures to the operators’ wrists and eyes showed no significant differences between the two catheterization routes. The difference was limited to thorax exposure.
“These data worry me,” commented Sunil V. Rao, MD, a long-time advocate for increased transradial catheterizations in U.S. practice. “We are pretty obsessive about radiation detection in our catheterization laboratory,” said Dr. Rao, an interventional cardiologist at Duke University in Durham, N.C.
The RAD-MATRIX substudy focused on the radiation exposures received by 14 participating operators who wore radiation dosimeters on their wrist, chest, and near their eyes during each procedure. All operators performed both transradial and transfemoral catheterizations with the choice dictated by the randomization protocol. The transradial procedures underwent further randomization to access through either the patient’s left or right arm. The full analysis included 398 procedures performed by transfemoral access, and 252 with transradial access with 131 via the left forearm and 121 via the right forearm.
The analysis showed that, when the operators performed transradial catheterizations, they received an average, normalized, effective dose to their thorax of 2.3 mcSv per procedure and 1.2 mcSv when performing transfemoral catheterization, a statistically significant difference. The exposures from left and from right transradial access did not differ significantly. Concurrently with Dr. Sciahbasi’s report at the meeting the results also appeared in an online article (J Am Coll Card. 2017 Mar 18. doi: 10.1016/j.jacc.2017.03.018).
The analysis also showed a 10-fold variability in exposure level among the 14 participating operators. Dr. Sciahbasi hypothesized that this reflected substantive differences in the degree of radiation protection used by each operator and suggested this implied that some interventionalists were not protecting themselves from exposure as thoroughly as possible.
RAD-MATRIX received partial funding from The Medicines Company and Terumo. Dr. Sciahbasi had no disclosures. Dr. Rao has been a consultant to Boehringer Ingelheim, Cardinal Health, Corindus, Cardiovascular Systems, and Medtronic.
mzoler@frontlinemedcom.com
On Twitter @mitchelzoler
AT ACC 17
Key clinical point:
Major finding: Transradial catheterizations delivered an average effective thorax radiation dose of 2.3 mcSv, compared with 1.2 mcSv from transfemoral catheterizations.
Data source: RAD-MATRIX, a randomized study with 14 operators who performed 650 total procedures.
Disclosures: RAD-MATRIX received partial funding from The Medicines Company and Terumo. Dr. Sciahbasi had no disclosures.